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Summary.-Formalin-fixed, paraffin-embedded sections of liver and tumour tissue
obtained at necropsy from 44 southern African Blacks with hepatocellular carcinoma
were stained for hepatitis-B virus surface antigen by immunofluorescence, immuno-
peroxidase and orcein techniques. The antigen was present in the serum of 68% of
the patients. Staining for tissue antigen was positive in 45% of the patients. Non-
tumorous hepatocytes alone stained positively in 22-5% of patients, tumour cells
alone in 12.5% and both in 10%. Antigen was present in relatively few tumour cells
and the amounts detected were small; it was more readily detectable in moderately
differentiated than in poorly differentiated malignant cells. Identical results were
obtained with immunofluorescence and immunoperoxidase staining, but the orcein
stain failed to demonstrate the antigen in tumour cells. Cirrhosis was present in the
non-tumorous liver in70o% of the patients. Antigen was detected in cirrhotic tissue
in43%0 of the patients with cirrhosis, and in non-tumorous liver tissue in8% of those
without cirrhosis, but this difference was not significant. The antigen frequency in
tumour tissue was the same in patients with and without cirrhosis. No correlation
was found between the presence of liver-cell dysplasia and the presence or absence
of either the antigen or cirrhosis in the non-tumorous liver tissue. Ground-glass
hepatocytes were seen in non-tumorous liver tissue of 5 patients, but not in tumour
tissue. While54% of the patients with antigenaemia had demonstrable tissue antigen,
10% of patients with tissue antigen had no detectable antigenaemia.
WHILE THERE IS undoubtedly a close
association between chronic hepatitis-B
virus (HBV) infection and hepatocellular
carcinoma (HCC), the nature of the asso-
ciation has not been elucidated, and there
is as yet no proofthat the virus causes the
tumour. Antigenic markers of HBV are
frequently found in the serum of patients
with HCC, particularly in those parts of
the world where this tumour is common
(Kew, 1978). Detection of these markers
in the non-tumorous liver tissue, whether
this is normal or cirrhotic, and especially
in the malignant cells themselves, might
provide more direct evidence for an onco-
genic role of the virus. Some information
in this regard is already available (Tan
et al., 1977; Nayak et al., 1977; Turbitt
et al., 1977; Trevisan et al., 1978). Cohen
et al. (1978) reported positive orcein
staining of paraffin sections of non-
tumorous liver tissue in 36% and of
tumour cells in 6% of southern African
Blacks with hepatocellular carcinoma. The
purpose of the present study was to
confirm and extend the latter findings,
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using specific immunofluorescence and
immunoperoxidase techniques in addition
to orcein staining.
MATERIALS AND METHODS
Patients studied.-The study was based on
44 southern African Blacks with HCC. These
patients were chosen because their serum
HBsAg status wasknown, and a necropsy was
performed. They were all males, their ages
at death ranging from 19 to 60 years, with a
mean of 36 years. Sixty per cent of the
patients were Shangaans from Mozambique,
while the remainder came from Malawi,
Transkei, Botswana, Zululand, Lesotho and
rural South Africa. Most of the patients had
received some form of cancer chemotherapy
at some time.
Tissue studies.-Blocks of HCC tissue and
non-tumorous liver tissue, each measuring
at least 1 cm2, were obtained at necropsy,
fixed in formalin and embedded in paraffin
in the usual way. Unstained sections mounted
on glass slides were coded and sent to Leuven
for examination after special staining. In
almost all cases two slides per patient were
studied. The patients' serum HBsAg status
was not made known to the histopathologists
responsible for examining the slides until
after completion of the study. In addition
to being prepared for routine histological
examination, all sections were stained with
the immunofluorescence, immunoperoxidase
and orceintechniques. Themethods usedhave
previously been described in detail: immuno-
fluorescence (Ray & Desmet, 1975); peroxi-
dase and anti-peroxidase (Burns, 1975;
Busachi et al., 1978); orcein staining (Shikata
et al., 1974). For control purposes, a known
positive and a known negative slide were
included in each batch of slides stained.
The specificity of all positive staining reac-
tions was checked, as described in previous
publications (Ray et al., 1974; Busachi et al.,
1978). In each case the presence or absence of
cirrhosis, liver cell dysplasia and ground-
glass hepatocytes was determined on sections
stained with haematoxylin and eosin. Dys-
plastic cells were identified according to the
criteria ofAnthony et al. (1973). The grading
system (0-4+) was based on the estimated
overall percentage of dysplastic cells in the
non-tumorous liver tissue: 0: absent; +:
25%; 2+: 25-50%; 3+: 50-75%; 4+:
75-100%.
Serum studies. HBsAg was detected in
the patients' sera by solid-phase radio-
immunoassay, using Ausria II-1251 (Abbot
Laboratories) (Ling & Overby, 1972). All
positive results were confirmed with the
neutralizing-antibody technique described
by Prince et al. (1973).
RESULTS
HBsAg in serum
HBsAg was detected in the sera of 30
of the 44 patients (68.2%; Table I). Of
the 26 patients with HBs antigenaemia,
and in whom both tumour and liver tissue
were present on the slides examined, 14
(54%) had evidence of HBsAg in the non-
tumorous liver and/or tumour tissue.
Fourteen of the 18 patients with positive
tissue staining had HBs antigenaemia.
Thus, in 4 patients (10%) HBsAg was
demonstrable in tissue but not in serum.
HBsAg in tissue
In 4 of the patients only tumour tissue
was present on the slides examined.
Evidence oftissue HBsAg was consistently
found in 18 patients (45%; Table I). The
tissue findings with the immunofluores-
cence and immunoperoxidase techniques
were identical, but overall fewer positive
results (13/40; 32.5%) were obtained with
the orcein stain (Table II). This was en-
tirely due to the fact that in none of the
slides did the tumour cells stain positively
with orcein. Ofthe 18 patients with tissue
HBsAg, the non-tumorous hepatocytes
alone were positive in 9 (22.5% of whole
group), the tumour cells alonewerepositive
in 5 (12.5%), and both were positive in 4
(10%; Tables I and II). Twenty-eight of
the 40 patients (70%) had cirrhosis in the
non-tumorous livertissue. This wasusually
of the macronodular type, though in some
cases it was a mixed macronodular-
micronodular cirrhosis. The distribution
of HBsAg in the tissues of the patients
with and without cirrhosis is shown in
Table II. Twelve of those with cirrhosis
(43%) had HBsAg in the cirrhotic tissue
(Fig. 1), while one of the 12 patients with-
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TABLE I.-Detailed results in individual
patients of HBsAg in tissues and serum
and of liver-cell dysplasia and ground-
glass cells
Tissue HBsAg
,A
patientswith cirrhosis (21.4%) had HBsAg
in tumour tissue (Fig. 2), while 3 of those
without cirrhosis (25%) had positive
tumour tissue (Table II).
Cellular distribution
Non-
tumor-
ous
Patient liver
HCC+
cirrhosis
1 -
2 -
3 -
4 +
5 +
6 +
7 +
8 -
9_
10 -
11 +
12 +
13 -
14 -
15 -
16 -
17 -
18 +
19 +
20 -
21 -
22 +
23 -
24 -
25 +
26 -
27 +
28 +
HCC
No cirrhiosis
29 -
30 -
31 -
32 -
33 -
34 -
35 -
36 -
37 -
38 -
39 +
40 -
HCC tissue
only
41
42
43
44
Ground-
glass
HCC hepato-
tissue cytes
+
+
+
+
+
+
+
+
+
+
+
Dys-
plastic
cells
+
+
+
+
++
++
+
+
++
++
++
++
+
+
+
+
++
++
+
++
++
+
+
++
++
+
Non-tumorous tissue.-In cirrhotic nod-
Serum ules, positively staining cells were fre-
HBsAg quently found in groups along the fibrous
septa. The remaining areas were either
+ entirelynegative or showed afew scattered
+ positive cells. The number of HBsAg-
+ containing hepatocytes was much lower
+ than that usually found inlivertissuefrom
+ patients with relatively inactive cirrhosis
+ (Ray et al., 1976). At an intracellular level
+ HBsAg showedmostly a focal cytoplasmic
- distribution.
+ HCC tissue.-Only a small number of
tumour cells were positive for HBsAg.
+ Furthermore, the amount of antigen in
+ the cells was small. HBsAg was found
+ only in the perinuclear area. The antigen
+ was more readily detectable in moderately
+ differentiated than in poorly differentiated
+ malignant cells.
+ Liver-cell dysplasia
+ This was looked for in the 40 patients
- in whom non-tumorous liver tissue was
+ present on the slides. Of these, 28 had
+
+
+
out cirrhosis (8.3%) had positive non-
tumorous hepatocytes (Table II). This
difference is not significant using the Yates
modification of the x2 test. Six of the
cirrhosis in the non-tumorous liver tissue.
HBsAg was demonstrable in the cirrhotic
tissue in 15 of the 28 patients, and 12 of
these had dysplastic cells (Fig. 3). These
cells were also present in 11 of the 13
patients in whom HBsAg was not seen in
the cirrhotic tissue. Of the 12 patients
without cirrhosis, dysplastic cells were
seen in all 3 in whom the tissue was
positive for HBsAg and in 6/9 without
positive staining. Thus, no correlation was
observed between the presence of dys-
plastic cells and the presence or absence
of either HBsAg or cirrhosis in the non-
tumorous liver tissue. There was no
definite pattern with regard to staining
ofindividual dysplastic cells with immuno-
fluorescence, immunoperoxidase or orcein
stains; some of the cells stained positively
while others did not. No correlation was
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FIG. 1.-Hepatocellular carcinoma with cirrhosis. HBsAg is demonstrated as dark brown deposits in
the cytoplasm of a group of non-tumorous hepatocytes. Orcein stain (x 320).
FIG. 2.-Hepatocellular carcinoma with cirrhosis. Indirect inumunofluorescence staining. HBsAg is
demonstrated in small amounts in different cytoplasmic locations in cancerous hepatocytes. In the
same area, PAP and orcein stainings gave strong non-specific background staining (x 320).
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found between the distribution of dys-
plastic cells and lobular topography in
non-cirrhotic liver tissue. However, in the
cirrhotic nodules dysplastic cells were
mostly found at the periphery of the
nodules. Liver cell dysplasia was present
in 19/24 patients (79%) with and 12/14
(96%) without HBs antigenaemia.
Ground-glass hepatocytes
Ground-glass cells were visualized in
non-cirrhotic liver tissue in I patient and
in cirrhotic tissue of 4patients. All ofthese
cells stained positively for HBsAg with
both immunohistochemical and orcein
stains. Noground-glass cells,"Tere observed
in tumour tissue.
DISCUSSION
Our findings agree, in the main, with
those of Cohen et al. (1978). The studies
were performed on similar patient popula-
tions, having nearly the same prevalence
of HBs antigenaemia, and differed only in
so far that we used immunospecific tech-
niques in addition to the orcein stain for
detecting HBsAg, whereas the eai-lier
investigation was confined to orceiii staiii-
ing. HBsAg was detected in the cytoplasm
of non-tumorous hepatocytes with equal
frequency (32-5 and 36%) in the two
studies. However, we found the cytoplasm
of the tumour cells to stain positivelv for
the antigen significantly more often than
Cohen et al. (1-978) (22-5 as auainst 6%).
Apossibleexplanation for this difference is
the relative insensitivity of the orcein
stain. This is suggested by ourfinding that
the 9 patients in whom tumour cells
stained positively for HBsAg with both
immunofluoreseence and immunoperoxi-
dase failed to do so with orcein , and that
when the antigen was detected in these
cells only small amounts were present.
With the greater quantities of HBsAg in
non-malignant hepatocytes, we found an
excellent correlation between the stainingTISSUE HBsAg IN HEPATOCARCINOMA
techniques. In a previous study from this
laboratory ofpatients with HBsAg-related
liver disease other than HCC, immuno-
fluorescence wasfound to be more sensitive
than orcein staining in detecting the
antigen (Ray et al., 1974). This observation
was confirmed recently when Turbitt
et al. (1977) found orcein staining less
sensitive than the immunoperoxidase tech-
nique in detecting HBsAg in hepatocellu-
lar carcinoma and cirrhosis. However, in
the study of Nayak et al. (1977) none of
the specimens which failed to stain with
orcein gave positive reactions with inmmu-
noperoxi(lase.
When patients from those parts of the
world where HCC and the HBV; carrier
state occur commonly have been studied,
high positivity rates of HBsAg in tissue
have been recorded (Hadziyannis et al.,
1976; Nayak et al., 1977; Tan et al.,
1977; Sumithran & Prathap, 1977). By
contrast, in Scotland, where both HCC
and chronic HBs antigenaemia are in-
frequent, only 10% of tissues stained
positively for HBsAg (Turbitt et al., 1977).
The prevalenice of tissue 1HBsAg in
southern African Blacks with this tumour
lies between the two extremes, which is
intriguing because the prevalence of HBs
antigenaemia is higher in the African
patients than in most or all of the other
H1CC populations studied (Kew, 1978).
The frequency with which HBsAg is
detected in tissue increases with the
adequacy of the sample (Nayak et al.,
1977). Both of the studies in southern
African Blacks were conducted onadequate
or reasonably adequate necropsy speci-
mens. Even with a single block of tissue,
Nayak et al. (1977) found a positivity rate
of 750°, which is appreciably greater than
the figure of 4000 in southern African
Blacks. One possible explanation for this
discrepancy might be inter-study dif-
ferences in the prevalence of cirrhosis in
the non-tumorous liver. Indeed, cirrhosis
was present in 920 of the patients in
whom HBsAg was found most often
(94%) in the non-tumorous liver (Nayak
et al., 1977). However, the prevalence of
cirrhosis in the other studies was not
dissimilar. Furthermore, HBsAg has also
been consistently detected in non-cirrhotic
liver tissue ofHCC patients.
In previous studies, HBsAg has rarely
been detected in tumour cells, the highest
incidence reported being the 8% found by
Nayak et al. (1977) in Indian patients. It
seems that the southern African Black
with HCC may be more likely than other
patients with this tumour to have the
antigen demonstrable in malignanthepato-
cytes (2255%). As was the case in other
studies (Hadziyannis et al., 1976; Nayak
et al., 1977; Turbitt et al., 1977) when
HBsAg was demonstrable in malignant
hepatocytes, the quantities were small.
The antigen had a different distribuition
in the tumour cells, occupying a peri-
nuclear position. It was more easily detect-
able in moderately differentiated than in
poorly differentiated tumours, confirming
previous observations (Nayak et al., 1977;
Trevisan et al., 1978). This observation,
together with the finding of IBsAg pre-
dominantly in the periphery of tumour
nodules, suggest that virus infection of
neoplastic cells may be an expression of
variable metabolic environments within
uniform cell clones. An alternative ex-
planation for the peripheral distribution
of the antigen is that normal hepatocytes
may become enmeshed in the growing edge
of the tumour, and it is these cells which
take up the stain.
As in previous studies, a few patients
without apparent HBs antigenaemia had
the antigen demonstrable in liver or
tumour tissue. This finding might be
explained by the antigen being present in
the patient's serum in too small an amount
to be detectable with present-day labora-
tory techniques. Alternatively, it is pos-
sible that, for some reason, H1BsAg in
tissue is not released into the blood. The
opposite picture (i.e. HBs antigenaemia
without detectable antigen in the tissues)
was more frequently seen. Examining
further blocks of tissue would increase the
tissue positivity rate somewhat, but
negative cases would undoubtedly remain.
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Again, it is possible that the antigen is
present in the tissues in suchsmallamounts
that it escapes detection. However, ifsome
patients were truly negative for the
antigen, this would indicate that HBV
cannot be incriminated in the aetiology
of all cases of HCC.
Liver-cell dysplasia was present in most
patients, both with and without cirrhosis
in the non-tumorous liver tissue, lending
support to the belief that this is a pre-
cancerous lesion (Anthony et al., 1973).
There was, however, no obvious correlation
between the presence of dysplastic cells
and the presence or absence of cirrhosis
or of HBsAg in either the tissues or the
serum. Only some of the dysplastic cells
stained positively with immunohisto-
chemical and orcein stains. There were
fewer HBsAg-positive hepatocytes in the
cirrhotic tissue than is normally found in
inactive cirrhosis, and relatively small
amounts of antigen in the positive cells.
Ground-glass hepatocytes were infre-
quently seen, and then usually in cirrhotic
tissue. All of these cells stained positively
with the immunohistochemical and orcein
techniques.
The findings in tissue studies to date
suggest that HBV is capable ofreplicating
not only in non-tumorous liver cells, but
also inthe HCC cells themselves. The latter
conclusion is supported by an HCC
growing in tissue culture which is pro-
ducing HBsAg (Macnab et al., 1976). How-
ever, these findings do not answer the
key question whether the virus is the cause
or the result ofthe tumour.
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